Trials / Completed
CompletedNCT00480896
Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment
Clinical Study on Tacrolimus Ointment Over the Long-term. "CONTROL Study - Children"
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 2 Years – 15 Years
- Healthy volunteers
- Not accepted
Summary
A long-term 0.03% tacrolimus ointment based regimen comprising of up to 6 weeks of initial twice daily treatment and subsequent twice weekly prophylactic application can effectively treat active lesions of atopic dermatitis, and prevent, delay, and reduce flares.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tacrolimus ointment | Topical application |
| DRUG | Placebo ointment | Topical application |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2005-11-01
- Completion
- 2005-11-01
- First posted
- 2007-05-31
- Last updated
- 2014-09-18
Locations
22 sites across 11 countries: Belgium, Czechia, Finland, France, Germany, Hungary, Italy, Netherlands, Portugal, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT00480896. Inclusion in this directory is not an endorsement.